Healthcare provider profile · identity verified

Laurence Michael Kish, MD

Internal Medicine · KINGS MOUNTAIN, NC · NPI 1740251503

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	576	152
Amlodipine Besylate	Amlodipine Besylate	523	147
Levothyroxine Sodium	Levothyroxine Sodium	350	94
Omeprazole	Omeprazole	325	87
Rosuvastatin Calcium	Rosuvastatin Calcium	317	96
Metformin Hcl	Metformin Hcl	284	83
Glimepiride	Glimepiride	268	72
Pantoprazole Sodium	Pantoprazole Sodium	268	67
Lisinopril	Lisinopril	242	60
Pravastatin Sodium	Pravastatin Sodium	220	58
Losartan Potassium	Losartan Potassium	213	64
Gabapentin	Gabapentin	211	63
Metoprolol Succinate	Metoprolol Succinate	205	56
Tamsulosin Hcl	Tamsulosin Hcl	183	52
Potassium Chloride	Potassium Chloride	175	44
Furosemide	Furosemide	174	58
Metformin Hcl Er	Metformin Hcl	149	35
Albuterol Sulfate Hfa	Albuterol Sulfate	148	38
Hydrochlorothiazide	Hydrochlorothiazide	143	40
Trazodone Hcl	Trazodone Hcl	140	39
Clopidogrel	Clopidogrel Bisulfate	134	32
Allopurinol	Allopurinol	124	33
Famotidine	Famotidine	123	42
Valsartan	Valsartan	121	40
Fluticasone Propionate	Fluticasone Propionate	120	48
Metoprolol Tartrate	Metoprolol Tartrate	115	35
Warfarin Sodium	Warfarin Sodium	107	23
Duloxetine Hcl	Duloxetine Hcl	106	34
Irbesartan	Irbesartan	104	23
Simvastatin	Simvastatin	104	26
Eliquis	Apixaban	92	18
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	86	19
Ezetimibe	Ezetimibe	86	28
Jardiance	Empagliflozin	81	23
Celecoxib	Celecoxib	79	22
Buspirone Hcl	Buspirone Hcl	77	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	74	20
Carvedilol	Carvedilol	73	22
Sertraline Hcl	Sertraline Hcl	69	18
Escitalopram Oxalate	Escitalopram Oxalate	68	19
Olmesartan Medoxomil	Olmesartan Medoxomil	68	20
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	65	22
Benazepril Hcl	Benazepril Hcl	60	16
Baclofen	Baclofen	59	26
Isosorbide Mononitrate Er	Isosorbide Mononitrate	58	13
Meloxicam	Meloxicam	57	22
Fenofibrate	Fenofibrate	54	suppressed
Ozempic	Semaglutide	54	14
Spironolactone	Spironolactone	52	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	15
Doxycycline Hyclate	Doxycycline Hyclate	48	45
Hydrocortisone	Hydrocortisone	47	16
Prednisone	Prednisone	45	33
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	12
Januvia	Sitagliptin Phosphate	43	15
Mirtazapine	Mirtazapine	43	suppressed
Montelukast Sodium	Montelukast Sodium	43	15
Ondansetron Odt	Ondansetron	43	17
Oxybutynin Chloride Er	Oxybutynin Chloride	42	14
Myrbetriq	Mirabegron	41	suppressed
Glipizide Er	Glipizide	40	13
Lovastatin	Lovastatin	39	12
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	39	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	38	14
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	37	suppressed
Trulicity	Dulaglutide	37	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	35	suppressed
Glipizide	Glipizide	35	suppressed
Hydralazine Hcl	Hydralazine Hcl	35	12
Mounjaro	Tirzepatide	35	suppressed
Synthroid	Levothyroxine Sodium	35	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Lansoprazole	Lansoprazole	33	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	33	29
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	32	11
Ibandronate Sodium	Ibandronate Sodium	30	11
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	29	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	11
Pregabalin	Pregabalin	29	11
Klor-Con M20	Potassium Chloride	28	12
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	28	suppressed
Valacyclovir	Valacyclovir Hcl	28	suppressed
Donepezil Hcl	Donepezil Hcl	27	11
Cefdinir	Cefdinir	26	25
Finasteride	Finasteride	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Novolog Flexpen	Insulin Aspart	25	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	25	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	23	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	suppressed
Mupirocin	Mupirocin	23	14
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Telmisartan	Telmisartan	23	suppressed
Naproxen	Naproxen	22	14
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	22	suppressed
Ramipril	Ramipril	22	suppressed
Ketoconazole	Ketoconazole	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Atenolol	Atenolol	20	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	18	suppressed
Tradjenta	Linagliptin	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Fluconazole	Fluconazole	17	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Nitroglycerin	Nitroglycerin	17	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Repatha Sureclick	Evolocumab	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Levofloxacin	Levofloxacin	16	16
Torsemide	Torsemide	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Methotrexate	Methotrexate Sodium	15	suppressed
Nystatin	Nystatin	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Flecainide Acetate	Flecainide Acetate	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Methylprednisolone	Methylprednisolone	14	14
Tramadol Hcl	Tramadol Hcl	14	11
Doxepin Hcl	Doxepin Hcl	13	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	13	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Sotalol Af	Sotalol Hcl	13	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Temazepam	Temazepam	12	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error